Hepamerz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

# Hepamerz (L-Ornithine L-Aspartate) ## Overview Hepamerz is a combination of L-ornithine and L-aspartate, amino acids used in the management of hyperammonemia, particularly in patients with liver insufficiency. It is believed to promote ammonia detoxification by stimulating the urea cycle and glutamine synthesis. ## Primary Indications * Treatment of latent and manifest hepatic encephalopathy (HE) associated with hyperammonemia. ## Adult Dosing * **Typical Dose:** 3 to 6 grams (which corresponds to 1 to 2 sachets or 10-20 mL of oral solution) three times daily. * **Maximum Dose:** While not strictly defined, doses up to 18 grams daily have been used in some studies. The exact maximum may depend on clinical response and local protocols. ## Pediatric Dosing * Dosing in pediatric patients is not well-established and should be determined by a specialist based on the individual child's condition and response. ## Dose Adjustments * No specific dose adjustments are routinely recommended for renal or hepatic impairment, as the drug is intended for patients with liver dysfunction. However, caution is advised. ## Contraindications * Hypersensitivity to L-ornithine L-aspartate or any of its components. * Severe kidney disease (renal failure) due to potential for accumulation of amino acids. * Lactic acidosis. * Urea cycle disorders (e.g., argininosuccinic aciduria). ## Adverse Effects * **Common:** Gastrointestinal disturbances such as nausea, vomiting, abdominal discomfort, and diarrhea. * **Less Common:** Dizziness, headache, fatigue. * **Rare:** Allergic reactions. ## Key Drug Interactions * No significant drug interactions have been widely reported. However, caution may be warranted with other medications affecting ammonia levels or renal function. ## Monitoring * Monitor for improvement in symptoms of hepatic encephalopathy. * Monitor electrolytes and renal function, especially in patients with pre-existing renal compromise. * Monitor ammonia levels, if available and indicated by clinical practice. ## Clinical Pearls * Hepamerz is typically administered orally as sachets or oral solution. * Treatment duration can vary from short-term to long-term, depending on the patient's condition and response. * The efficacy and safety of Hepamerz are primarily studied in the context of liver disease; its use in other conditions is off-label. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before using any medication.